Surgical valve technologies

Concomitant minimally invasive surgery for tricuspid valve papillary fibroelastoma and right lung cancer in an elderly patient: a case report and review of the literature

Published on 16/11/2023 | Wang Yalin 1 et al. | Journal of Cardiothoracic Surgery 2023; 18(1): 315 | 9 minute read

Abstract Background It is very common for patients with newly diagnosed lung masses to have heart disease. However, papillary fibroelastomas

Surgical valve technologies

Anesthetic management with remimazolam in very elderly patients undergoing hybrid surgery of transcatheter aortic valve implantation plus off-pump coronary artery bypass grafting: report of two cases

Published on 02/11/2023 | Oyoshi Takafumi 1 et al. | JA Clinical Reports 2023; 9(1): 69 | 12 minute read

Abstract Background Remimazolam is a short-acting benzodiazepine with small circulatory depression. We used remimazolam for general anesthesia management in two

Surgical valve technologies

Transcatheter aortic valve replacement 23 years after heart transplant for aortic insufficiency

Published on 19/10/2023 | Jones Andrew 1 et al. | Journal of Cardiothoracic Surgery 2023; 18(1): 273 | 9 minute read

Abstract Background Clinicians continue to expand the availability of transcatheter aortic valve replacement (TAVR) for patients who historically would have

Surgical valve technologies

Bicuspid aortic valve and its ascending aortopathy

Published on 05/10/2023 | Dunne et al. | Current Opinion in Pediatrics 2023; 35(5): 538-45 | 19 minute read

Abstract Purpose of review To synthesize and critically assess recent clinical and research advancements in pediatric bicuspid aortic valve (BAV)

Surgical valve technologies

Aortic valve Replacement compared to Transcatheter Implant and its relationship with COgnitive Impairment (ARTICO) evaluated with neuropsychological and advanced neuroimaging: a longitudinal cohort study

Published on 21/09/2023 | Gomis Meritxell 1 et al. | BMC Neurology 2023; 23(1): 310 | 33 minute read

Abstract Background Aortic stenosis is the most common valvulopathy in Western countries. The treatment of choice had been surgery aortic

Surgical valve technologies

Clinical outcomes and progression rate of tricuspid regurgitation in patients with rheumatic mitral valve disease

Published on 07/09/2023 | Mônica M Costa Caldas 1 et al. | Open Heart 2023; 10(2): e002295 | 22 minute read

Abstract Objective A substantial proportion of patients with rheumatic heart disease (RHD) have tricuspid regurgitation (TR). This study aimed to

Surgical valve technologies

Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Published on 17/08/2023 | StephanDobnerMD et al. | Journal of the American Heart Association 2023; 12(16): 030271 | 21 minute read

Abstract Background The prevalence of calcific aortic stenosis and amyloid transthyretin cardiomyopathy (ATTR‐CM) increase with age, and they often coexist.

Surgical valve technologies

Cardiac reverse remodeling in primary mitral regurgitation: mitral valve replacement vs. mitral valve repair

Published on 03/08/2023 | Craven Thomas P. 1 et al. | Journal of Cardiovascular Magnetic Resonance 2023; 25(1): 43 | 39 minute read

Abstract Background When feasible, guidelines recommend mitral valve repair (MVr) over mitral valve replacement (MVR) to treat primary mitral regurgitation

Surgical valve technologies

Renin–angiotensin system inhibition after surgical aortic valve replacement for aortic stenosis

Published on 20/07/2023 | Andreas Martinsson 1 et al. | Heart 2023; aop:10.1136/heartjnl-2023-322922 | 20 minute read

Abstract Objective The optimal medical therapy after surgical aortic valve replacement (SAVR) for aortic stenosis remains unknown. Renin–angiotensin system (RAS)

Surgical valve technologies

Trans-axillary approach enhances postoperative recovery after mitral valve surgery

Published on 06/07/2023 | Pietro Giorgio Malvindi et al. | European journal of cardio-thoracic surgery 2023; aop: 10.1093/ejcts/ezad207 | 18 minute read

/home/gnm/gcebuket/archivesrobot/phaseIV/2023/06/01/oxford_2017/5939201_Transaxillaryapproachenha/Full_text_PDF/5939201_Transaxillaryapproachenha Manuscript including tables 1 Title: Trans-axillary approach enhances postoperative recovery after mitral valve surgery 2 Running title: Trans-axillary approach for minimally invasive mitral valve surgery 3 Pietro Giorgio Malvindi1*, Manuel Wilbring2*, Veronica De Angelis2, Olimpia Bifulco1,3, Paolo Berretta1, Utz Kappert2, Marco Di Eusanio1 4 5 1- Cardiac Surgery Unit, Lancisi Cardiovascular Center, Ospedali Riuniti delle Marche, Polytechnic 6 University of Marche, Ancona, Italy 7 2- Center for Minimally Invasive Cardiac

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.